Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Operating Expenses (2016 - 2025)

Historic Operating Expenses for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $101.1 million.

  • AtriCure's Operating Expenses rose 735.26% to $101.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.5 million, marking a year-over-year increase of 1237.37%. This contributed to the annual value of $387.5 million for FY2024, which is 1849.36% up from last year.
  • Per AtriCure's latest filing, its Operating Expenses stood at $101.1 million for Q3 2025, which was up 735.26% from $107.7 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Operating Expenses registered a high of $107.7 million during Q2 2025, and its lowest value of -$46.4 million during Q3 2021.
  • For the 5-year period, AtriCure's Operating Expenses averaged around $76.9 million, with its median value being $81.2 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first crashed by 20477.83% in 2021, then skyrocketed by 25596.75% in 2022.
  • Quarter analysis of 5 years shows AtriCure's Operating Expenses stood at $67.5 million in 2021, then grew by 2.56% to $69.2 million in 2022, then grew by 27.78% to $88.5 million in 2023, then rose by 21.09% to $107.1 million in 2024, then dropped by 5.62% to $101.1 million in 2025.
  • Its Operating Expenses was $101.1 million in Q3 2025, compared to $107.7 million in Q2 2025 and $98.6 million in Q1 2025.